STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

Small, D, Levenstein, M, Kim, E, Carow, C, Amin, S, Rockwell, P, Witte, L, Burrow, C, Ratajczak, M Z, Gewirtz, A M·1994·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.91.2.459

Cited by (431)

Items 301–400 of 431

  1. Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations
    Uichi Nishiyama, Tetsuya Yoshino, Masako Ozai, Rieko Yoshioka, Motoko Fujisawa, Yuko Ogasawara, Miyuki Kitahori, Eiji Yoshioka, Kazuo Kubo, Yukiko Komeno et al. · 2006 · Leukemia Research
  2. Stem cells and stem cell factor(s)
    Carmelo Carlo‐Stella, Vittorio Rizzoli · 1995 · PubMed
  3. Environmental Requirements of Hematopoietic Progenitor Cells in Ex Vivo Expansion Systems
    Peter W. Zandstra, Connie J. Eaves, James M. Piret · 1999 · Elsevier eBooks
  4. Oligonucleotide-Based Therapeutics of Human Malignancies
    Mariusz Z. Ratajczak, Alan M. Gewirtz · 1994 · Nucleic acids and molecular biology
  5. Understanding Gene Expression Patterns in Immune-Mediated Disorders
    Russell L. Dedrick · 2007 · Journal of Immunotoxicology
  6. Targeted Signal Transduction Therapies in Myeloid Malignancies
    Emma Scott, Elizabeth Olson Hexner, Alexander E. Perl, Martin P Carroll · 2010 · Current Oncology Reports
  7. Risk assessment of FLT3 and PAX5 variants in B-acute lymphoblastic leukemia: a case–control study in a Pakistani cohort
    Ammara Khalid, Sara Aslam, Mehboob Ahmed, Shahida Hasnain, Aimen Aslam · 2019 · PeerJ
  8. CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009
    Curt I. Civin · 2010 · Transfusion
  9. Co‐administration of Flt‐3 ligand counteracts the actions of thrombopoietin in myelosuppressed rhesus monkeys
    Simone C.C. Hartong, Karen J. Neelis, Gerard Wagemaker · 2003 · British Journal of Haematology
  10. Genetic Abnormalities as Targets for Molecular Therapies in Myelodysplastic Syndromes
    Daniela Cilloni, Emanuela Messa, Francesca Messa, Sonia Carturan, Ilaria Defilippi, Francesca Arruga, Valentina Rosso, Renata Catalano, Enrico Bracco, Paolo Nicoli et al. · 2006 · Annals of the New York Academy of Sciences
  11. The effect of human fit‐ 3 ligand on committed progenitor cell production from normal, aplastic anaemia and Diamond‐Blackfan anaemia bone marrow
    John Scopes, Stephen Daly, Sarah E. Ball, COLIN P. McGUCKIN, E. C. Gordon‐Smith, Frances M. Gibson · 1995 · British Journal of Haematology
  12. Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia—Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022
    Małgorzata Czogała, Wojciech Czogała, Katarzyna Pawińska-Wąsikowska, Teofila Książek, Karolina Bukowska-Straková, Barbara Sikorska‐Fic, Pawel Jozef Laguna, Anna Izabela Fałkowska, Katarzyna Anna Drabko, Katarzyna Maria Muszyńska-Rosłan et al. · 2023 · Cancers
  13. High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
    Fabiana Cacace, Rossella Iula, Danilo De Novellis, Valeria Caprioli, Maria Rosaria D’Amico, Giuseppina De Simone, Rosanna Cuccurullo, William G. Wierda, Kris Michael Mahadeo, Giuseppe Menna et al. · 2022 · Biomedicines
  14. Activating Mutations and Targeted Therapy in Cancer
    Musaffe Tuna, Isis L. Christopher · 2012 · InTech eBooks
  15. The plant mannose‐binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long‐term culture and enhances their ex vivo expansion
    Karen Li, Vincent E. C. Ooi, Carmen Ka Yee Chuen, Audrey Carmen Lam, Linda S. M. Ooi, Xiao Bing Zhang, Kam Sze Tsang, Lawrence C.M. Chiu, Kathy Yuen Yee Chan, Chi Kong Li et al. · 2007 · British Journal of Haematology
  16. Are cup-like blasts specific to AML patients with FLT3 ITD and a normal karyotype? An ALL case report and review of the literature
    Özgür Mehtap, Elif Birtaş Ateşoğlu, Emel Orge Gonullu, Hakan Keski, Abdullah Hacıhanefioğlu · 2011 · Turkish Journal of Hematology
  17. Ex vivo cytokine expansion of peripheral blood 5‐fluorouracil‐treated CD34‐positive chronic myeloid leukaemia cells increases the selection of Ph‐negative cells
    François‐Xavier Mahon, V. Pigeonnier, Hikmat Chahine, Caroline Barbot, Bożena Jaźwiec, Jean Ripoche, Josy J. Reiffers · 1997 · British Journal of Haematology
  18. Stem cell manipulation: why and how performing peripheral blood progenitor cell purging
    Vittorio Rizzoli, Carmelo Carlo‐Stella · 1997 · Critical Reviews in Oncology/Hematology
  19. Allelic loss of the FMS gene in acute myeloid leukaemia
    Hugh McGlynn, Katrina Kapelko, Andrew Howard Baker, Alan K. Burnett, Rose Ann Padua · 1997 · Leukemia Research
  20. Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: A literature review
    Naveera Zafar, Kulsoom K. Ghias, Zehra Fadoo · 2020 · Asia-Pacific Journal of Clinical Oncology
  21. The c-myb proto-oncogene: a novel target for human gene therapy
    Alan M. Gewirtz · 1996 · Cancer treatment and research
  22. Biology of Flt3 Ligand, a Novel Regulator of Hematopoietic Stem and Progenitor Cells
    Hilary J. McKenna, Stewart D. Lyman · 1996 · Springer eBooks
  23. Molecular Testing of FLT3 Mutations in Hematolymphoid Malignancies in the Era of Next-generation Sequencing
    Shunsuke Koga, Wei Feng Du, Guang Yang, Linsheng Zhang · 2025 · Journal of Clinical and Translational Pathology
  24. Flt3 ligand
    Stewart D. Lyman, Hilary J. McKenna · 2003 · Elsevier eBooks
  25. Distinct Gene Mutations, their Prognostic Relevance and Molecularly Targeted Therapies in Acute Myeloid Leukemia (AML)
    Muhammad Tayyab · 2014 · Journal of Cancer Science & Therapy
  26. Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
    João Agostinho Machado‐Neto, Fabı́ola Traina, Mariana Lazarini, Paula de Melo Campos, Kátia Bórgia Barbosa Pagnano, Irene G.H. Lorand-Metze, Fernando Ferreira Costa, Sara Teresinha Olalla Saad · 2011 · Clinics
  27. Early progenitor cells from human mobilized peripheral blood express low levels of the flt3 receptor, but exhibit various biological responses to flt3‐L
    Thérèse Aurran, Anne‐Marie Imbert, Laurent M. P. F. Humeau, Florence Bardin, Pierre Charbord, Christian Chabannon · 1999 · British Journal of Haematology
  28. Transfer of drug resistance genes in hematopoietic progenitors for chemoprotection: is it still an option?
    Stephanie Laufs, Eike C. Buss, Walter Jens Zeller, Stefan Früehauf · 2003 · Drug Resistance Updates
  29. Comprehensive FLT3 analysis in Indian acute myeloid leukaemia
    Shalvi V. Mehta, Shilin Nandubhai Shukla, Hemangini H. Vora · 2012 · Journal of Blood & Lymph
  30. Fibroblast Growth Factors and Early Hemopoietic Cell Development
    Mariusz Z. Ratajczak · 1997 · Leukemia & lymphoma/Leukemia and lymphoma
  31. Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML
    Gray Magee, Michael Richard Grunwald · 2025 · Current Treatment Options in Oncology
  32. A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule
    Iraj Hosseini, Brett Fleisher, Jennifer A. Getz, Jérémie Decalf, Mandy Kwong, Meric Ovacik, Travis W. Bainbridge, Christine Moussion, Gautham K. Rao, Kapil G. Gadkar et al. · 2024 · Pharmaceutics
  33. Downregulation of DDIT4 levels with borneol attenuates hepatotoxicity induced by gilteritinib
    Yiming Yin, Yashi Cao, Yourong Zhou, Zhifei Xu, Peihua Luo, Bo Yang, Qiaojun He, Hao Yan, Xiaochun Yang · 2025 · Biochemical Pharmacology
  34. Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia
    Junqing Wang, Yingying Chen, Dongdong Ji, Ling Ge, Yu Xin Zhang, Lixia Liu, Lei Jiang, Fengbo Jin, Leiming Xia · 2025 · European journal of medical research
  35. Prevalence of FMS-like tyrosine kinase 3/internal tandem duplication (FLT3/ITD+) in de novo acute myeloid leukemia patients categorized according to cytogenetic risk
    Everson Augusto Krum, Mihoko Yamamoto, Maria de Lourdes Chauffaille · 2009 · Sao Paulo Medical Journal
  36. Quantum Dreaming: The Relevance of Quantum Mechanics to Regional Science
    Tony Sörensen · 2011 · EPubDev Repository
  37. Fms-Related Tyrosine Kinase 3 Expression Discriminates Hematopoietic Stem Cells Subpopulations With Differing Engraftment-Potential: Identifying the Most Potent Combination
    Yiming Huang, Mariusz Z. Ratajczak, Ryan Reca, Hong Xu, Michael K. Tanner, Francine Rezzoug, Lala-Rukh Hussain, Isabelle Vivier, Roberto Bolli, Suzanne T. Ildstad · 2008 · Transplantation
  38. Differential effect of interferon α on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co‐culture context: role of the flt3 ligand
    Anne Solanilla, Abdel El Andaloussi, Christophe François Grosset, Pascale Duchez, M. Djavad Mossalayi, François‐Xavier Mahon, Josy J. Reiffers, Gérald Marit, Jean Ripoche · 2000 · British Journal of Haematology
  39. The Transcription Factor Repertoire of Flt3+ Hematopoietic Stem Cells
    Thomas Hieronymus, David Ruau, Julia L. Ober-Blöbaum, Jea-Hyun Baek, Alexandra Rolletschek, Stefan Rose‐John, Anna M. Wobus, Albrecht M. Müller, Martin Zenke · 2008 · Cells Tissues Organs
  40. Oligonucleotide therapeutics for human leukemia
    Mariusz Z. Ratajczak, Alan M. Gewirtz · 1998 · Birkhäuser Basel eBooks
  41. Targeting mutant kinases in Gastrointestinal Stromal Tumors: A paradigm for molecular therapy of other sarcomas
    Michael Charles Heinrich, Christopher L. Corless · 2006 · Kluwer Academic Publishers eBooks
  42. Antigen association of J6-1 cell membrane associated factor receptor with macrophage colony stimulating factor receptor
    Rao Qing, Jingshu Han, Geng Yiqi, Shouqing Luo, 马冠杰, Zheng Dexian, Zheng Guoguang, Ke‐Fu Wu · 1999 · Chinese Journal of Cancer Research
  43. Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
    Christopher Edward Jensen, Nathan D. Montgomery, Jonathan Galeotti, Matthew Charles Foster, Joshua F. Zeidner · 2022 · Journal of Cellular and Molecular Medicine
  44. The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia
    Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Gaia Stanzione, Anna Maria Zimbo, Elisabetta Lugli et al. · 2024 · Expert Review of Hematology
  45. Establishment of a cost-effective method to detect FLT-ITD and D835 mutations in acute myeloid leukemia patients in the Taiwanese population
    Hsingjin Eugene Liu, Ching Huai Ko, Freda Lam, Lawrence Shih-Hsin Wu, Kuei-Fang Lee · 2015 · Tzu Chi Medical Journal
  46. Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia
    Michela Palmisano, Tiziana Grafone, Matteo Renzulli, Emanuela Ottaviani, Nicoletta Testoni, Stefania Paolini, Cristina Papayannidis, Michele Baccarani, Giovanni Martinelli · 2008 · Hematology
  47. The Challenge of t(6;9) and FLT3-Positive Acute Myelogenous Leukemia in a Young Adult
    Yeohan Song Dale Bixby · 2014 · Journal of Leukemia
  48. Intraembryonic Development of Hematopoietic Stem Cells during Human Ontogeny: Expression Analysis
    Caroline J. Marshall · 2006 · Springer eBooks
  49. The Steel Factor/kit Ligand/Stem Cell Factor
    Stewart D. Lyman, Anthony R. Mire‐Sluis, Brian Gliniak · 1998 · Elsevier eBooks
  50. Nucleic Acid Therapeutics for Human Leukemia: Development and Early Clinical Experience with Oligodeoxynucleotides Directed at c-myb
    Alan M. Gewirtz · 1998 · Handbook of experimental pharmacology
  51. Anti-Human FLT3 Monoclonal Antibody That Inhibits Proliferation of Monocytic Leukemia Cell Line SHI-1
    Songguang Ju, Zhi-mou Xue, Songwen Ju, Yan Ge, Wei Xie, Huanting Zhu, Jian-zhong Pan, Xueguang Zhang · 2011 · Hybridoma
  52. Impact of FLT3 mutation on its intracellular localization and implications for anti-leukemia strategy
    Fei Song, Long Su, Sujun Gao · 2025 · Annals of Hematology
  53. Recent advances in targeted therapy of human myelogenous leukaemia
    Keren Paz, Zhenping Zhu · 2005 · Expert Opinion on Therapeutic Targets
  54. Effect of FLT3 ligand on survival and disease phenotype in murine models harboring a FLT3 internal tandem duplication mutation.
    Emily Bailey, Amy S. Duffield, Sarah Merin Greenblatt, Peter D. Aplan, Donald Small · 2013 · Europe PMC (PubMed Central)
  55. Cytokines
    Walter M. Lewko, Robert K. Oldham · 2009 · Springer eBooks
  56. Différenciation des cellules hématopoïétiques : intervention des cytokines et expression des marqueurs membranaires
    Mohamed Bidri, Michel Arock · 1996 · Revue Française d Allergologie et d Immunologie Clinique
  57. Le Flt3-ligand plasmatique, un bio-indicateur pronostique de l'atteinte radio-induite à la moelle osseuse
    Jean‐Marc Bertho, Johanna Frick, Christelle Demarquay, J. Ph. Laporte, J. Aigueperse, Norbert Claude Gorin, P. Gourmelon · 2001 · Radioprotection
  58. Flt‐3 ligand does not induce the growth of peripheral blood granulocyte‐macrophage colony‐forming cells in myeloproliferative disorders
    Timo Siitonen, Eeva‐Riitta Savolainen, P. Koistinen · 1999 · European Journal Of Haematology
  59. Isolation and Characterization of a Monoclonal Antibody Binding to the Extracellular Domain of the flk-2 Tyrosine Kinase Receptor
    CAROLINE ROSE, Patricia Rockwell, J. Yang, Bronislaw Pytowski, Neil I. Goldstein · 1995 · Hybridoma
  60. FLT3 Antibody-based therapy for leukemia
    Yiwen Li · 2006 · Drug Development Research
  61. New Cytokines and their Clinical Application
    Ian McNiece · 1999 · Cancer treatment and research
  62. Oligonucleotide Therapeutics for Human Leukemia
    Alan M. Gewirtz · 1998 · Springer eBooks
  63. French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study
    Andy Garnham, Franck Bruon, Céline Berthon, Delphine Lebon, Mounika Parimi, R Polya, Kahina M. Makhloufi, Marie-Hélène Dramard-Goasdoue · 2023 · Oncology and Therapy
  64. Next Generation Sequencing in Oncological Diagnostics: Hype or Hope?
    Rana Hallak, Manfred Küpper, Amer Al Chikh Youssef · 2024 · Journal of Biosciences and Medicines
  65. Overcoming the sorafenib resistance mechanism in FLT3-mutated acute myeloid leukemia: molecular basis and new targets
    Hui Peng, Min Li, Yuan Yuan Peng, Xiao Lan Li, Jing Yang, Qiang Ge Sun, Kui Song · 2025 · Frontiers in Oncology
  66. Design, synthesis, and evaluation of pyrido.[3,4-b]pyrazin-2(1H)-one derivatives as potent FLT3 inhibitors
    Mei Sun, Chang Wang, Peipei Wang, Qingqing Ye, Yubo Zhou, Jia Xuan Li, Tao Liu · 2023 · Bioorganic & Medicinal Chemistry
  67. Olverembatinib (HQP1351): a third-generation tyrosine kinase inhibitor in the treatment of hematologic and solid malignancies—a comprehensive review of clinical outcomes
    Sina Sadati, Sara Yazdizadeh, Seyed Mohsen Razavi, Mina Homayoonfal, Gordon A Ferns, Fatemeh Divani, Hamed Mirzaei · 2026 · Discover Oncology
  68. FLT3 in AML
    Naval Guastad Daver, Farhad Ravandi · 2014 · Springer eBooks
  69. Absence of FLT3 and JAK2 (V617F) mutations in Langerhans cell histiocytosis
    Malak Abedalthagafi, Huimin Guo, Dan-Paul Hartmann, Metin Özdemirli · 2009 · Leukemia Research
  70. Molecular Diagnostics in Adult Acute Myeloid Leukemia
    Annika M. Svensson, Youjun Hu · 2012 · North American Journal of Medicine and Science
  71. Expression of FLT3 and FLT3 Ligand in Human Leukemia-Lymphoma Cell Lines
    Guido Meierhoff, Uwe Dehmel, H J Gruss, Wilhelm Gerhard Dirks, Hans Günter Drexler · 1997 · Hämatologie und Bluttransfusion
  72. MULTIDIMENSIONAL ROLE OF CD34 PROTEIN IN HEMATOPOIETIC STEM CELL BIOLOGY
    Vimal Kishor Singh, Kohichiro Tsuji · 2012
  73. SIMULTANEOUS INHIBITION OF DRIVER AND EFFECTOR KINASES PROMOTES POTENT GROWTH ARREST OF AML CELLS IN VITRO AND IN VIVO
    Mark C. Weir · 2016 · D-Scholarship@Pitt (University of Pittsburgh)
  74. Formation and Differentiation of Leukocytes
    Douglas E. Wright, Irving L. Weissman · 2001 · Springer eBooks
  75. Exploring structure and plasticity of tyrosine kinase domains for drug discovery
    Loris Moretti · 2007 · reroDoc Digital Library
  76. Receptors for hematopoietic regulatory cytokines: Overview of structure and function
    Urban Gullberg, Gösta Bergh, Mats Ehinger, Inge Olsson · 1995 · Cancer treatment and research
  77. Proliferation of Human Progenitor Cells in a Long-term Culture System is More Efficiently Sustained by the Addition of Flt-3 Ligand or Megakaryocyte Growth and Development Factor than by Kit Ligand
    Guillaume Cartron, C Binet, Olivier Hérault, C. Cailliot, M. C. Bernard, Marie‐Hélène Estienne, N. Clément, Philippe Colombat, Jorge Domenech · 2003 · International Journal of Hematology
  78. Regulation of B-cell differentiation by stromal cells
    E. A. Faust, Douglas C. Saffran, Owen N. Witte · 1995 · Elsevier eBooks
  79. FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype
    Sang-Ho Kim, Yeo‐Kyeoung Kim, Il-Kwon Lee, Deog‐Yeon Jo, Jong-Ho Won, Jae‐Yong Kwak, Chang‐Yeol Yim, Moo‐Rim Park, Deok‐Hwan Yang, Sang‐Hee Cho et al. · 2007 · The Korean Journal of Hematology
  80. Cytokines
    Walter M. Lewko, Robert K. Oldham · 2003 · Springer eBooks
  81. Activated FLT3 Receptor Tyrosine Kinase as a Therapeutic Target In Leukemia
    Blanca Scheijen, James D. Griffin · 2006 · Humana Press eBooks
  82. Selektion, ex-vivo Expansion und Analyse der Differenzierungskapazität humaner CD133 positiver Stammzellen aus dem peripheren Blut
    Sonja Loges · 2004
  83. Up-regulation of CD11c Expression on Human Acute Myelogenous Leukemia Cells by Flt-3 Ligand
    Qi Xu · 2009 · Journal of Life Science
  84. Expression and function of GDNF family ligands and their receptors by human immune cells
    Vivian Vargas · 2004 · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München)
  85. Kinase Inhibitors in Leukemia
    Mark J. Levis, Donald Small · 2004 · Advances in pharmacology
  86. Studies on signaling pathways induced by FLT3, an important oncogene in AML
    Elena Razumovskaya · 2011 · Lund University Publications (Lund University)
  87. FLT3: A Prototype Receptor Tyrosine Kinase Target in AML
    Mark J. Levis · 2007 · Humana Press eBooks
  88. Characterization of the Proteins HPIP and VENTX2 as Novel Regulatory Proteins of Human Hematopoiesis
    Natalia Arseni · 2006 · Site cant be reached
  89. Expression and characterization of the recombinant human FLT-3 ligand extracellular domain in Pichia pastoris
    Zongtang Huang, Xishan Hao · 2006 · Chinese Journal of Clinical Oncology
  90. Prognostic Significance of FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype
    Ja Young Lee, Young Don Joo, Seung Hwan Oh, Jeong Hwan Shin, Hye Ran Kim, Sang Min Lee, Jeong Nyeo Lee · 2009 · The Korean Journal of Hematology
  91. Extraction and biomedical application of peripheral blood stem cells in sheep and horses
    Aliki V. Strydom · 2007 · SUNScholar (Stellenbosch University)
  92. Tyrosine kinase Flt3/Flt3-ligand signaling in the modulation of immune responses in experimental arthritis
    Mattias N. D. Svensson · 2014 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  93. Levels Cells Reveals FLT3 as a Modulator of IL-10 RNA Interference Screen in Primary Human T
    Stephen M. Anderton, David A. Hafler, Nir Hacohen, Anne Astier, Gaëlle Bériou, Thomas Eisenhaure · 2011
  94. In vitro und in vivo Charakterisierung von Endothelvorläuferzellen
    Frauenschuh, Jörg · 2006
  95. Cellular and Molecular Aspects of Myeloid Cell Proliferation and Development
    Caroline A. Evans, Andrew Pierce · 1996 · Blood cell biochemistry
  96. Homing and engraftment of CD34+ cells in the NOD/SCID model
    Forhad Ahmed · 2005 · OpenGrey (Institut de l'Information Scientifique et Technique)
  97. FLT3/ITD Expression Increases Expansion, Survival and Entry into Cell Cycle of Human Hematopoietic Stem Cells.
    Li Li, Obdulio Piloto, Kyu-Tae Kim, Zhaohui Ye, Bao Nguyen, Xiaobing Yu, Mark J. Levis, Linzhao Cheng, Donald Small · 2004 · Blood
  98. FMS-related tyrosine kinase 3
    Soheil Meshinchi, Derek L. Stirewalt · 2013 · Cambridge University Press eBooks
  99. The role of Pim-1 in breast cancer metastasis
    Lara Jupp · 2017 · Minerva Access (University of Melbourne)
  100. Genomics of Acute Myeloid Leukemia
    Zeeshan Ahmed, Imran Ahmed Siddqui, Sadia Sultan · 2018 · InTech eBooks